Mostrar el registro sencillo del ítem

Artículo

dc.creatorSalmanton-García, Jones
dc.creatorMarchesi, Francescoes
dc.creatorGlenthøj, Andreases
dc.creatorBilgin, Yavuz M.es
dc.creatorVan Praet, Jenses
dc.creatorDávila-Valls, Julioes
dc.creatorEspigado Tocino, Ildefonsoes
dc.creatorPagano, Livioes
dc.date.accessioned2023-10-25T15:01:52Z
dc.date.available2023-10-25T15:01:52Z
dc.date.issued2022
dc.identifier.citationSalmanton-García, J., Marchesi, F., Glenthøj, A., Bilgin, Y.M., Van Praet, J., Dávila-Valls, J.,...,Pagano, L. (2022). Improved Clinical Outcome of COVID-19 in Hematologic Malignancy Patients Receiving a Fourth Dose of Anti-SARS-CoV-2 Vaccine: An EPICOVIDEHA Report. HemaSphere, 6 (11). https://doi.org/10.1097/HS9.0000000000000789.
dc.identifier.issn2572-9241es
dc.identifier.urihttps://hdl.handle.net/11441/149904
dc.formatapplication/pdfes
dc.format.extent4 p.es
dc.language.isoenges
dc.relation.ispartofHemaSphere, 6 (11).
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.titleImproved Clinical Outcome of COVID-19 in Hematologic Malignancy Patients Receiving a Fourth Dose of Anti-SARS-CoV-2 Vaccine: An EPICOVIDEHA Reportes
dc.typeinfo:eu-repo/semantics/articlees
dcterms.identifierhttps://ror.org/03yxnpp24
dc.type.versioninfo:eu-repo/semantics/publishedVersiones
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses
dc.contributor.affiliationUniversidad de Sevilla. Departamento de Medicinaes
dc.relation.publisherversionhttps://journals.lww.com/hemasphere/fulltext/2022/11000/improved_clinical_outcome_of_covid_19_in.6.aspxes
dc.identifier.doi10.1097/HS9.0000000000000789es
dc.journaltitleHemaSpherees
dc.publication.volumen6es
dc.publication.issue11es

FicherosTamañoFormatoVerDescripción
Improved...pdf323.1KbIcon   [PDF] Ver/Abrir  

Este registro aparece en las siguientes colecciones

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como: Attribution-NonCommercial-NoDerivatives 4.0 Internacional